Temperature-controlled Packaging for Pharmaceutical Market is predicted to reach USD 24,130 Million at a CAGR of 9.2% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Temperature-controlled Packaging for Pharmaceutical Market”.

The Metal Foundry Products market is estimated to register a CAGR of 9.2% during the forecast period of 2024 to 2032.

MRFR recognizes the following companies as the key players in the Global Temperature-controlled Packaging for Pharmaceutical market— Sonoco Thermosafe, UNITED PARCEL SERVICE AMERICA, INC, kaneka Corporation, DHL International GmbH, Deutsche Bahn AG, Cold Chain Technologies, LLC, EMBALL’ISO, Inmark, LLC, kuehne + nagel inc., CSafe Global, va-Q-tec AG, and many more.

Temperature Controlled Packaging Pharmaceutical Market Highlights

The Global Temperature-controlled Packaging for Pharmaceutical market is accounted for to register a CAGR of 9.2% during the forecast period and is estimated to reach USD 24,130 Million by 2032.

Temperature-controlled packaging for pharmaceuticals, as the name suggests a form of packaging that offers a specific range of temperature to maintain and secure the quality and integrity of the range of pharmaceutical products. Temperature-controlled packaging provides the required necessary protection to the pharmaceuticals throughout transportation. The ability of temperature-controlled packaging to offer an extensive range of packaging temperatures for pharmaceutical products raises its demand and popularity among pharmaceutical brand owners. Temperature-controlled packaging helps pharmaceutical brand owners to keep the pharmaceutical medicines safe and fully effective throughout their supply chain. Temperature-controlled packaging can stabilize the internal packaging environment with relevant safety regulations and quality standards regardless of the external environment. The future demand and sales outlook for temperature-controlled packaging for pharmaceuticals is projected to remain promising on the back of rapidly rising manufacturing output from the global pharmaceutical industry. This report has segmented the global temperature-controlled packaging for pharmaceutical market based on product, type, temperature range, payload capacity, medicine type, use, and end-use industry.

Access full report @ https://www.marketresearchfuture.com/reports/temperature-controlled-packaging-pharmaceutical-market-7190

Segment Analysis

The Global Temperature-controlled Packaging for Pharmaceutical market has been segmented into product, type, temperature range, payload capacity, medicine type, use, and end-use industry.

Based on product, the global temperature-controlled packaging for pharmaceutical market is segmented into Shippers and Containers. The Shippers product segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. Cold shipment boxes protect temperature-sensitive products throughout transport and delivery, and shippers keeps refrigerated and frozen. Corrugated and foam-only expanded polystyrene (EPS) shippers provide safety and economy without leaching dangerous chemicals during use or disposal. Polyurethane (PUR) shippers insulate better than equivalent-thickness EPS containers, while vacuum insulated panel (VIP) shippers prevent heat damage during long shipping. They're used to keeping things fresh and effective as part of the cold chain. Parcel shipping systems are another name for shippers. These may transport temperature-sensitive cargo with a volume ranging from 4 to 100 liters.

 Based on type, the global temperature-controlled packaging for pharmaceutical market is segmented into Active System and Passive System. The Passive System type segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. Standard water-based refrigerants and insulated containers/shippers are considered passive systems, as are specialized refrigerants or phase-change materials. Passive containers are appropriate for usage in a regulated room temperature (CRT) environment or as general protection for low-risk cargo. Inside an insulated enclosure, a passive container provides a temperature-controlled environment. This can be done with or without thermostatic regulation and with or without using a finite amount of pre-conditioned coolants such as chilled or frozen gel packs, phase transition materials, or dry ice. Polystyrene, polyurethane, or vacuum insulated panels are commonly used to insulate passive containers. Many are designed to maintain a specific temperature for a set payload capacity for up to 96 hours.

Based on temperature range, the global temperature-controlled packaging for pharmaceutical market is segmented into -20°C and Below, -20°C to 0°C, 2°C to 8°C, 8°C to 25°C, and Above 25°C. The 8°C to 25°C temperature range segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. When working in the pharmaceutical industry, maintaining the proper cool temperature for the storage of specific items is critical. Medical product testing, medicine stability, and the safeguarding of high-value medical items all require high-cool storage. Pharmaceutical firms who want to increase the quality of their product while expanding their storage capacity may consider investing in cool storage. Storage chambers provide high-value controlled cooling environments for a range of products and can be suited to meet the needs of your industry. Large portion/range of pharmaceutical items pack, transport, and store in the given temperature range.

Based on payload capacity, the global temperature-controlled packaging for pharmaceutical market is segmented into Up to 10 L, 10 L - 20 L, 20 L - 40 L, 40 L - 150 L, and Above 150 L. The Up to 10 L payload capacity segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. In up to 10 L, the base is designed with the choice of a 100mm-high base or four fixed 150mm-high legs and four tray shelves, each with a 10 L capacity with the Height of base/legs (mm) (1,950 / 2,000), Width (500) and insulated bag version in several sizes or insulated backpack. Possibility to create bespoke and personalized insulated shippers and containers for your marketing needs. The up to 10 L segment currently accounts for the largest market share.

Based on use, the global temperature-controlled packaging for pharmaceutical market is segmented into Single Use and Reusable. Single Use segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. The market's largest usability segment is single use. The necessary containers that can only hold one shipment. Compared to reusable packaging systems, these containers offer a lighter and less expensive option. With the disposal of containers, the packaging system tends to generate packaging waste. The single-use container market is driven by its convenience, allowing for unlimited distribution, and eliminating the need to return containers to their original location. These containers are ideal for use in isolated areas where reverse logistics are impossible. In the forecast period, the market for single-use packaging solutions is likely to be driven by rising demand for pharmaceutical or biopharma goods (vaccines, cell and gene therapy, and clinical trials). Because of its disposable nature, the single-use category leads the market. However, due to sustainable steps made by pharmaceutical packaging specialists, the reusable category is expected to increase rapidly over the projection period.

Based on medicine type, the global temperature-controlled packaging for pharmaceutical market is segmented into Temperature Sensitive Pharmaceutical Drugs, Vaccine, and Regenerative Medicine. Temperature Sensitive Pharmaceutical Drugs medicine type segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. Some drugs, such as insulin, are unaffected by cold or heat. To keep medicine safe, set strict packing and shipping requirements for temperature-sensitive products at express scripts. The manufacturer keeps drugs and US Pharmacopeia between 68-77°F (20-25°C). While ambient temperature refers to the air temperature in each environment, room temperature refers to the temperature range most people feel at ease. A thermometer determines ambient temperature, whereas room temperature is determined by feeling.

Based on end use industry, the global temperature-controlled packaging for pharmaceutical market is segmented into Pharmaceuticals and Clinical Trails. The pharmaceuticals end use industry segment is expected to dominate the global temperature-controlled packaging for the pharmaceutical market during the forecast period. The pharmaceutical segment will deliver higher performance than the latter throughout the forecast period. The pharmaceutical segment can perform well owing to the supply of drugs and blood to patients at hospitals and critical care centers. Pharma industries include products derived from synthetic or chemical processes (artificial sources). Medicines and other pharmaceuticals are among its offerings. Temperature variations, humidity, and other factors can cause pharmaceuticals to be damaged. As a result, the products are delivered worldwide in temperature-controlled packaging. The market for temperature-controlled packaging solutions is expected to be driven by rising pharmaceutical product demand during the forecast period.

Regional Analysis

The global temperature-controlled packaging for pharmaceutical market, based on region, has been divided into North America, Europe, Asia Pacific, and Rest of the World. North America consists of US and Canada. Europe consists of UK, Germany, France, Italy, Spain, and Rest of Europe. Asia-Pacific consists of China, India, Japan, Sout Korea, Taiwan, Philippines, Indonesia, Thailand, Malaysia, Singapore, Hong Kong, Australia, and Rest Of Asia-Pacific. The rest of the world consists of the Middle East & Africa and South America.

North America accounted for the largest market share in 2023 and is expected to register the highest CAGR during the forecast period. Due to various lifestyle disorders, many patients, and high disposable income levels, North America is likely to be a highly profitable market during the forecast period. Pharmaceutical product safety regulations, as well as a growing geriatric population, may raise regional market demand. The market may benefit from bilateral trade agreements and increased international trade. Active systems have a considerable market in North America. Compared to the passive system, the active system provides the best level of temperature accuracy. For long-distance shipping, the active system maintains a constant temperature. The system is capable of effectively managing supply chain delays. With the availability of a power source, temperature excursions are less likely. The US Food and Drug Administration (FDA) has set a distribution practice regulation that stipulates that drugs must be supplied at the proper temperatures.

Asia Pacific held the second largest share in the market for global temperature-controlled packaging for pharmaceuticals and is anticipated to ascend at a revenue based CAGR over the forecast period. Because of the surge in infectious diseases and the necessity for cold chain solutions to preserve vaccines, APAC is thought to be tremendously profitable. Leading players operating in the global temperature-controlled packaging for pharmaceutical market can target the highly potential Asian countries to maximize their financial revenues. As the market gets more concentrated, the region is expected to see more acquisitions. Due to the significant rise in chronic diseases and the increasing number of clinical trials in countries such as China and India, Asia-Pacific is predicted to develop at a higher rate during the projection period. Asia-Pacific has seen technological improvements on the back of its burgeoning population and increasing disease outbreaks.

The European Union (EU) authorities enforced a slew of new criteria for pharmaceutical packaging on fake pharmaceuticals in 2017, and Europe is predicted to grow significantly during the projection period. Anti-counterfeiting technologies, such as overt, covert, and forensic technology, have been applied by EU authorities for pharmaceutical packaging, resulting in pharmaceutical packaging companies in the region continuing to develop packaging methods and procedures. Regional packaging companies are using innovative strategies to improve their current portfolio. Bormioli Pharma S.p.A., an Italian glass and plastic packaging manufacturer announced in 2019 that it would use a more open, distributed approach to reach more consumers, merging internal R&D projects with start-ups and incubators. The company also announced that it would create a new organizational structure that would combine marketing and innovation functions. Such factors are expected to propel the regional market during the forecast period.

The Rest of World comprises of The Middle East and Africa and South America. The Middle East & Africa market is expected to rise significantly, owing to rising per capita disposable income, rising healthcare awareness, and rising pharmaceutical and drug consumption. Furthermore, the region is characterized by a growing manufacturing capacity and rising investments in the pharmaceutical packaging industry. The increasing pharmaceutical sector in Saudi Arabia is driving the pharmaceutical packaging market in the region. In South Africa, generic pharmaceuticals account for about half of the pharmaceutical market. This has resulted in a rise in the demand for drug and pharmaceutical packaging in South Africa. During the projected period, such factors are likely to fuel the region’s expansion of the Temperature-Controlled Packaging for Pharmaceutical market. Furthermore, the pharmaceutical sector in South America is expanding at a healthy rate, owing to many people being diagnosed with various ailments. Furthermore, the need for medical and healthcare centers is increasing, as is the consumption of pharmaceuticals. Brazil, Argentina, Chile, and Colombia contribute significantly to the region's total.

Key Findings of the Study

• The global temperature-controlled packaging for pharmaceuticals market is expected to reach USD 24,130 Million by 2032, at a CAGR of 9.2% during the forecast period.


• North America accounted for the largest market share in 2023 and is expected to register the highest CAGR during the forecast period. Due to various lifestyle disorders, many patients, and high disposable income levels, North America is likely to be a highly profitable market during the forecast period.


• Based on type, the Passive System type segment was attributed to holding the largest market in 2023.


• Sonoco Thermosafe, UNITED PARCEL SERVICE AMERICA, INC, kaneka Corporation, DHL International GmbH, Deutsche Bahn AG, Cold Chain Technologies, LLC, EMBALL’ISO, Inmark, LLC, kuehne + nagel inc., CSafe Global, va-Q-tec AG, and many more, are the key players in the market.


• Based on end-use industry, the pharmaceuticals end use industry segment held the largest market share in 2023.


• Based on product, the Shippers product segment application segment held the largest market share in 2023.